Search Results - "Brieva, L"

Lipid profile of cerebrospinal fluid in multiple sclerosis patients: a potential tool for diagnosis by Nogueras, L., Gonzalo, H., Jové, M., Sol, J., Gil-Sanchez, A., Hervás, J. V., Valcheva, P., Gonzalez-Mingot, C., Solana, M. J., Peralta, S., Pamplona, R., Brieva, L.

“…Multiple sclerosis (MS) is a complex multifactorial neuropathology. Although its etiology remains unclear, it has been demonstrated that the immune system…”
Get full text

Comparison of two high doses of oral methylprednisolone for multiple sclerosis relapses: a pilot, multicentre, randomized, double‐blind, non‐inferiority trial by Hervás‐García, J. V., Ramió‐Torrentà, L., Brieva‐Ruiz, L., Batllé‐Nadal, J., Moral, E., Blanco, Y., Cano‐Orgaz, A., Presas‐Rodríguez, S., Torres, F., Capellades, J., Ramo‐Tello, C.

“…Background and purpose Oral or intravenous methylprednisolone (≥500 mg/day for 5 days) is recommended for multiple sclerosis (MS) relapses. Nonetheless, the…”
Get full text

A randomized clinical trial of oral versus intravenous methylprednisolone for relapse of MS by Ramo-Tello, C, Grau-López, L, Tintoré, M, Rovira, A, Ramió i Torrenta, L, Brieva, L, Cano, A, Carmona, O, Saiz, A, Torres, F, Giner, P, Nos, C, Massuet, A, Montalbán, X, Martínez-Cáceres, E, Costa, J

“…Background: Steroids improve multiple sclerosis (MS) relapses but therapeutic window and dose, frequency and administration route remain uncertain. Objective:…”
Get full text

Recommendations for vaccination in patients with multiple sclerosis who are eligible for immunosuppressive therapies: Spanish consensus statement by Otero-Romero, S, Rodríguez-García, J, Vilella, A, Ara, J R, Brieva, L, Calles, C, Carmona, O, Casanova, V, Costa-Frossard, L, Eichau, S, García-Merino, J A, Garcia-Vidal, C, González-Platas, M, Llaneza, M, Martínez-Ginés, M, Meca-Lallana, J E, Prieto, J M, Rodríguez-Antigüedad, A, Tintoré, M, Blanco, Y, Moral, E

“…BACKGROUNDThe recent development of highly effective treatments for multiple sclerosis (MS) and the potential risk of infectious complications require the…”
Get full text

Monitoring response to disease-modifying treatment in multiple sclerosis by Río, J., Peña, J., Brieva, L., García-Domínguez, J.M., Rodríguez-Antigüedad, A., Oreja-Guevara, C., Costa-Frossard, L., Arroyo, R.

“…Standard criteria for defining suboptimal response to disease-modifying treatment (DMT) in patients with multiple sclerosis (MS) are lacking. Decision-making…”
Get full text

Communication with families regarding organ and tissue donation after death in intensive care (COMFORT): A multicentre before-and-after study by Potter, Julie E, Perry, Lin, Elliott, Rosalind M, Aneman, Anders, Brieva, Jorge L, Cavazzoni, Elena, Cheng, Andrew Th, O'Leary, Michael J, Seppelt, Ian M, Herkes, Robert G

“…Objective: To implement a best-practice intervention offering deceased organ donation, testing whether it increased family consent rates. Design: A multicentre…”
Get full text

A single-center, randomized, double-blind, placebo-controlled study of interferon beta-1b on primary progressive and transitional multiple sclerosis by Montalban, X., Sastre-Garriga, J., Tintoré, M., Brieva, L., Aymerich, FX, Río, J., Porcel, J., Borràs, C., Nos, C., Rovira, À.

“…Inflammation and neurodegeneration may have differential impacts on disease evolution in the different forms of multiple sclerosis. However, a beneficial…”
Get full text

Direct costs of relapses in patients with relapsing-remitting multiple sclerosis by V. Casado, I. Bonaventura, L. Brieva, S. Martínez-Yélamos, G. Martín, S. Presas-Rodriguez, M. Hervas, J.J. Hernández, E. Munteis, A. Escartin, L. Gubieras, M.A. Mañé-Martínez, L. Ramió-Torrentà

“…Introduction: Effective treatments that reduce relapses can diminish the impact on MS costs in the long-term. This study aims to estimate direct costs of RRMS…”
Get full text

Gadolinium-enhanced brain lesions in multiple sclerosis relapse by Martín-Aguilar, L., Presas-Rodriguez, S., Rovira, À., Capellades, J., Massuet-Vilamajó, A., Ramió-Torrentà, L., Tintoré, M., Brieva-Ruiz, L., Moral, E., Cano-Orgaz, A., Blanco, Y., Batlle-Nadal, J., Carmona, O., Gea, M., Hervás-García, J.V., Ramo-Tello, C.

“…OBJECTIVETo study the clinico-radiological paradox in multiple sclerosis (MS) relapse by analyzing the number and location of gadolinium-enhanced (Gd+) lesions…”
Get full text

Recommendations for vaccination in patients with multiple sclerosis who are eligible for immunosuppressive therapies: Spanish consensus statement by Otero-Romero, S., Rodríguez-García, J., Vilella, A., Ara, J.R., Brieva, L., Calles, C., Carmona, O., Casanova, V., Costa-Frossard, L., Eichau, S., García-Merino, J.A., Garcia-Vidal, C., González-Platas, M., Llaneza, M., Martínez-Ginés, M., Meca-Lallana, J.E., Prieto, J.M., Rodríguez-Antigüedad, A., Tintoré, M., Blanco, Y., Moral, E.

“…The recent development of highly effective treatments for multiple sclerosis (MS) and the potential risk of infectious complications require the development of…”
Get full text

Incidence of contrast-induced nephropathy in intensive care patients undergoing computerised tomography and prevalence of risk factors by RASHID, A. H, BRIEVA, J. L, STOKES, B

“…Computerised tomography (CT) with contrast is frequently used in intensive care. Contrast-induced nephropathy (CIN) is an important complication largely…”
Get full text

Patterns of diffusion-weighted magnetic resonance imaging associated with etiology improve the accuracy of prognosis after transient ischaemic attack by Purroy, F., Begué, R., Gil, M. I., Quílez, A., Sanahuja, J., Brieva, L., Piñol-Ripoll, G.

“…Objective:  Diffusion‐weighted magnetic resonance imaging (DWI) is a sensitive diagnostic tool for detecting acute ischaemic lesions in patients with transient…”
Get full text

Primary Sjogren Syndrome with Tumefactive Central Nervous System Involvement by Sanahuja, J, Ordonez-Palau, S, Begue, R, Brieva, L, Boquet, D

“…Brain MR imaging abnormalities in primary Sjögren syndrome (pSS) are generally discrete white matter lesions. We describe a 50-year-old woman with recurrent…”
Get full text

Progression on the Multiple Sclerosis Functional Composite in multiple sclerosis: what is the optimal cut-off for the three components? by Bosma, LVAE, Kragt, JJ, Brieva, L., Khaleeli, Z., Montalban, X., Polman, CH, Thompson, AJ, Tintoré, M., Uitdehaag, BMJ

“…For the Timed 25-Foot Walk (T25FW) and 9-Hole Peg Test (9HPT), components of the Multiple Sclerosis Functional Composite (MSFC), cut-off points of 20% change…”
Get full text

Predictive value of ankle brachial index in patients with acute ischaemic stroke by Purroy, F., Coll, B., Oró, M., Setó, E., Piñol-Ripoll, G., Plana, A., Quílez, A., Sanahuja, J., Brieva, L., Vega, L., Fernández, E.

“…Background:  The ankle brachial index (ABI) is a known measure of lower‐limb peripheral artery disease (PAD), as well as a marker for other cardiovascular…”
Get full text

Similar biological effect of high-dose oral versus intravenous methylprednisolone in multiple sclerosis relapses by Grau-López, L, Teniente-Serra, A, Tintoré, M, Rovira, A, Ramió-Torrenta, L, Brieva, L, Saiz, A, Cano, A, Carmona, O, Hervás, JV, Martínez-Cáceres, EM, Ramo-Tello, C

“…Our aim was to investigate differences in immune mechanisms in multiple sclerosis (MS) relapse, after high-dose oral methylprednisolone (oMP) or intravenous…”
Get full text

Transient effect of inhaled fluticasone on airway mucosal blood flow in subjects with and without asthma by KUMAR, S. D, BRIEVA, J. L, DANTA, I, WANNER, A

“…Topically applied glucocorticosteroids (GS) have been shown to cause local vasoconstriction in normal skin and this phenomenon is commonly used to assess the…”
Get full text

Withholding and Withdrawal of Life-sustaining Therapies in Intensive Care: An Australian Experience by Brieva, Jorge L, Cooray, Prashanth, Rowley, Martin

“…Objectives: Withholding and withdrawal of treatment in intensive care is currently widely accepted, but little has been published about Australian practice…”
Get full text

Effect of an inhaled glucocorticosteroid on airway mucosal blood flow in mild asthma by BRIEVA, J. L, DANTA, I, WANNER, A

“…We determined airway mucosal blood flow (Qaw) and FEV (1) before and after inhaled albuterol in 19 glucocorticosteroid (GS)-naive patients with mild…”
Get full text

Isolated demyelinating syndromes: comparison of CSF oligoclonal bands and different MR imaging criteria to predict conversion to CDMS by Tintoré, M., Rovira, A., Brieva, L., Grivé, E., Jardí, R., Borrás, C., Montalban, X.

“…To evaluate and compare the capacity of oligoclonal bands (OB) and three sets of MR imaging criteria to predict the conversion of clinically isolated syndromes…”
Get full text